Skip to main content
. 2015 Aug 12;2015:390428. doi: 10.1155/2015/390428

Table 2.

Expression of E-cadherin, α-SMA, TLR4, NF-κB p65, IL-1β, and MCP-1 in the tubulointerstitial tissues by immunohistochemistry (mean ± SD).

NC (n = 10) DM (n = 10) TL (n = 10) TM (n = 10) TH (n = 10)
E-cadherin 3.21 ± 0.58 0.27 ± 0.16a 1.01 ± 0.29a,b 2.46 ± 0.37a,b,c 2.62 ± 0.41a,b,c
α-SMA 0.24 ± 0.15 3.19 ± 0.29a 2.63 ± 0.21a,b 2.14 ± 0.18a,b,c 1.57 ± 0.20a,b,c,d
TLR4 0.19 ± 0.12 2.92 ± 0.17a 2.24 ± 0.18a,b 1.73 ± 0.15a,b,c 1.29 ± 0.14a,b,c,d
NF-κB 0.35 ± 0.19 4.12 ± 0.21a 3.81 ± 0.22a,b 3.09 ± 0.17a,b,c 1.94 ± 0.19a,b,c,d
IL-1β 0.31 ± 0.11 3.48 ± 0.24a 2.89 ± 0.15a,b 2.19 ± 0.15a,b,c 1.96 ± 0.17a,b,c
MCP-1 0.36 ± 0.09 3.07 ± 0.26a 2.31 ± 0.12a,b 1.54 ± 0.18a,b,c 1.15 ± 0.15a,b,c,d

NC: normal control; DM: diabetic rats without drug treatment; TL: low-dose TGT (1 mg/kg/day); TM: medium-dose TGT (3 mg/kg/day); TH: high-dose TGT (6 mg/kg/day). a p < 0.05 versus NC group, b p < 0.05 versus DM group, c p < 0.05 versus TL group, and d p < 0.05 versus TM group.